![Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance | Clinical Cancer Research Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance | Clinical Cancer Research](https://clincancerres.aacrjournals.org/sites/default/files/highwire/clincanres/24/13.cover-source.jpg)
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance | Clinical Cancer Research
![Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers - Offin - 2019 - Cancer - Wiley Online Library Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers - Offin - 2019 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/476a66ed-b4a6-4179-82d4-2d4be0cd8189/cncr.v125.24.cover.jpg)
Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers - Offin - 2019 - Cancer - Wiley Online Library
![Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy - Jordan - Journal of Gastrointestinal Oncology Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy - Jordan - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/15152/public/15152-PB10-R1.png/w300)